296 related articles for article (PubMed ID: 22528165)
1. STAR VaS--Short Term Atorvastatin Regime for Vasculopathic Subjects: a randomized placebo-controlled trial evaluating perioperative atorvastatin therapy in noncardiac surgery.
Neilipovitz DT; Bryson GL; Taljaard M
Can J Anaesth; 2012 Jun; 59(6):527-37. PubMed ID: 22528165
[TBL] [Abstract][Full Text] [Related]
2. Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial.
Durazzo AE; Machado FS; Ikeoka DT; De Bernoche C; Monachini MC; Puech-Leão P; Caramelli B
J Vasc Surg; 2004 May; 39(5):967-75; discussion 975-6. PubMed ID: 15111846
[TBL] [Abstract][Full Text] [Related]
3. Atorvastatin has an important acute anti-inflammatory effect in patients with acute coronary syndrome: results of a randomized, double-blind, placebo-controlled study.
Macin SM; Perna ER; Farías EF; Franciosi V; Cialzeta JR; Brizuela M; Medina F; Tajer C; Doval H; Badaracco R
Am Heart J; 2005 Mar; 149(3):451-7. PubMed ID: 15864233
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and tolerability of atorvastatin/fenofibrate fixed-dose combination tablet compared with atorvastatin and fenofibrate monotherapies in patients with dyslipidemia: a 12-week, multicenter, double-blind, randomized, parallel-group study.
Davidson MH; Rooney MW; Drucker J; Eugene Griffin H; Oosman S; Beckert M;
Clin Ther; 2009 Dec; 31(12):2824-38. PubMed ID: 20110022
[TBL] [Abstract][Full Text] [Related]
5. Alternate-day versus daily atorvastatin in coronary artery disease: a randomized study.
Rifaie O; Zahran A; Nammas W
Anadolu Kardiyol Derg; 2012 Mar; 12(2):90-6. PubMed ID: 22281786
[TBL] [Abstract][Full Text] [Related]
6. Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study.
Patti G; Chello M; Candura D; Pasceri V; D'Ambrosio A; Covino E; Di Sciascio G
Circulation; 2006 Oct; 114(14):1455-61. PubMed ID: 17000910
[TBL] [Abstract][Full Text] [Related]
7. Effects of atorvastatin on inflammatory and fibrinolytic parameters in patients with chronic kidney disease.
Goicoechea M; de Vinuesa SG; Lahera V; Cachofeiro V; Gómez-Campderá F; Vega A; Abad S; Luño J
J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S231-5. PubMed ID: 17130267
[TBL] [Abstract][Full Text] [Related]
8. Patients with stable coronary artery disease receiving chronic statin treatment who are undergoing noncardiac emergency surgery benefit from acute atorvastatin reload.
Xia J; Qu Y; Shen H; Liu X
Cardiology; 2014; 128(3):285-92. PubMed ID: 24903511
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: the Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in non-insulin-dependent diabetes mellitus (ASPEN).
Knopp RH; d'Emden M; Smilde JG; Pocock SJ
Diabetes Care; 2006 Jul; 29(7):1478-85. PubMed ID: 16801565
[TBL] [Abstract][Full Text] [Related]
10. High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study.
Kinlay S; Schwartz GG; Olsson AG; Rifai N; Leslie SJ; Sasiela WJ; Szarek M; Libby P; Ganz P;
Circulation; 2003 Sep; 108(13):1560-6. PubMed ID: 12975259
[TBL] [Abstract][Full Text] [Related]
11. Continuation of statin therapy in patients with presumed infection: a randomized controlled trial.
Kruger PS; Harward ML; Jones MA; Joyce CJ; Kostner KM; Roberts MS; Venkatesh B
Am J Respir Crit Care Med; 2011 Mar; 183(6):774-81. PubMed ID: 20959555
[TBL] [Abstract][Full Text] [Related]
12. Effects of atorvastatin on systemic inflammatory response after coronary bypass surgery.
Chello M; Patti G; Candura D; Mastrobuoni S; Di Sciascio G; Agrò F; Carassiti M; Covino E
Crit Care Med; 2006 Mar; 34(3):660-7. PubMed ID: 16505650
[TBL] [Abstract][Full Text] [Related]
13. Short-term therapy with high dose atorvastatin in patients with coronary artery disease can reduce inflammatory process.
Nesar Hossein V; Yosef Nejad K; Abdollahian F
Acta Med Iran; 2010; 48(4):218-21. PubMed ID: 21279932
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the efficacy and tolerability of pitavastatin and atorvastatin: an 8-week, multicenter, randomized, open-label, dose-titration study in Korean patients with hypercholesterolemia.
Lee SH; Chung N; Kwan J; Kim DI; Kim WH; Kim CJ; Kim HS; Park SH; Seo HS; Shin DG; Shin YW; Shim WJ; Ahn TH; Ho Yun K; Yoon MH; Cha KS; Choi SW; Han SW; Hyon MS
Clin Ther; 2007 Nov; 29(11):2365-73. PubMed ID: 18158077
[TBL] [Abstract][Full Text] [Related]
15. Atorvastatin for the treatment of plaque-type psoriasis.
Faghihi T; Radfar M; Mehrabian Z; Ehsani AH; Rezaei Hemami M
Pharmacotherapy; 2011 Nov; 31(11):1045-50. PubMed ID: 22026392
[TBL] [Abstract][Full Text] [Related]
16. Perioperative statin therapy for improving outcomes during and after noncardiac vascular surgery.
Sanders RD; Nicholson A; Lewis SR; Smith AF; Alderson P
Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD009971. PubMed ID: 23824754
[TBL] [Abstract][Full Text] [Related]
17. High-dose statin and COX-2 inhibitor therapy rapidly decreases C-reactive protein level in patients with unstable angina.
Chyrchel M; Dudek D; Bartuś S; Legutko J; Heba G; Dubiel JS
Kardiol Pol; 2004 Sep; 61(9):213-21; discussion 222-4. PubMed ID: 15531933
[TBL] [Abstract][Full Text] [Related]
18. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis.
Wanner C; Krane V; März W; Olschewski M; Mann JF; Ruf G; Ritz E;
N Engl J Med; 2005 Jul; 353(3):238-48. PubMed ID: 16034009
[TBL] [Abstract][Full Text] [Related]
19. Comparison of intensive and low-dose atorvastatin therapy in the reduction of carotid intimal-medial thickness in patients with coronary heart disease.
Yu CM; Zhang Q; Lam L; Lin H; Kong SL; Chan W; Fung JW; Cheng KK; Chan IH; Lee SW; Sanderson JE; Lam CW
Heart; 2007 Aug; 93(8):933-9. PubMed ID: 17344325
[TBL] [Abstract][Full Text] [Related]
20. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
